Advertisement

Index by Author

November 1990; 39 (11)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Andrews, K M

    • Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes. Diabetes November 1990 39:1414-1419; doi:10.2337/diabetes.39.11.1414

  2. Armstrong, G R

    • Abnormal redox status without increased lipid peroxidation in sugar cataract. Diabetes November 1990 39:1347-1352; doi:10.2337/diabetes.39.11.1347

B

  1. Bailey, C J

    • Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes November 1990 39:1326-1332; doi:10.2337/diabetes.39.11.1326

  2. Bascal, Z A

    • Abnormal redox status without increased lipid peroxidation in sugar cataract. Diabetes November 1990 39:1347-1352; doi:10.2337/diabetes.39.11.1347

  3. Bell, P A

    • Inhibition of hepatic glucose production by SDZ 51641. Diabetes November 1990 39:1408-1413; doi:10.2337/diabetes.39.11.1408

  4. Bennett, P H

    • Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes November 1990 39:1430-1435; doi:10.2337/diabetes.39.11.1430

  5. Bergman, R N

    • Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes November 1990 39:1361-1365; doi:10.2337/diabetes.39.11.1361

  6. Bhathena, S

    • Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes November 1990 39:1436-1444; doi:10.2337/diabetes.39.11.1436

  7. Bonnet, B

    • Structural abnormality in LDL from diabetic patients as revealed by resonance Raman spectroscopy. Diabetes November 1990 39:1451-1456; doi:10.2337/diabetes.39.11.1451

  8. Bossoni, S

    • Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes November 1990 39:1333-1338; doi:10.2337/diabetes.39.11.1333

  9. Braaten, J T

    • Long-term culture of neonatal rat pancreatic endocrine cells as model for insulin-secretion and ion-channel studies. Diabetes November 1990 39:1353-1360; doi:10.2337/diabetes.39.11.1353

  10. Brichard, S M

    • Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes November 1990 39:1326-1332; doi:10.2337/diabetes.39.11.1326

  11. Butler, P C

    • Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes November 1990 39:1373-1380; doi:10.2337/diabetes.39.11.1373

C

  1. Caldonazzo, A

    • Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes November 1990 39:1333-1338; doi:10.2337/diabetes.39.11.1333

  2. Charles, M A

    • Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes November 1990 39:1361-1365; doi:10.2337/diabetes.39.11.1361

  3. Cimino, A

    • Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes November 1990 39:1333-1338; doi:10.2337/diabetes.39.11.1333

  4. Cohen, D K

    • Inhibition of hepatic glucose production by SDZ 51641. Diabetes November 1990 39:1408-1413; doi:10.2337/diabetes.39.11.1408

  5. Colette, C

    • Structural abnormality in LDL from diabetic patients as revealed by resonance Raman spectroscopy. Diabetes November 1990 39:1451-1456; doi:10.2337/diabetes.39.11.1451

  6. Cooper, D R

    • Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes November 1990 39:1399-1407; doi:10.2337/diabetes.39.11.1399

  7. Cravarezza, P

    • Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes November 1990 39:1333-1338; doi:10.2337/diabetes.39.11.1333

D

  1. Dahl, D C

    • Effect of bacitracin on retroendocytosis and degradation of insulin in cultured kidney epithelial cell line. Diabetes November 1990 39:1339-1346; doi:10.2337/diabetes.39.11.1339

  2. Davis, M D

    • Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C-peptide and diabetic retinopathy. Diabetes November 1990 39:1445-1450; doi:10.2337/diabetes.39.11.1445

  3. DeMets, D L

    • Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C-peptide and diabetic retinopathy. Diabetes November 1990 39:1445-1450; doi:10.2337/diabetes.39.11.1445

  4. Duckworth, W C

    • Effect of bacitracin on retroendocytosis and degradation of insulin in cultured kidney epithelial cell line. Diabetes November 1990 39:1339-1346; doi:10.2337/diabetes.39.11.1339

F

  1. Farese, R V

    • Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes November 1990 39:1399-1407; doi:10.2337/diabetes.39.11.1399

  2. Flood, J F

    • Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes November 1990 39:1391-1398; doi:10.2337/diabetes.39.11.1391

  3. Foley, J E

    • Inhibition of hepatic glucose production by SDZ 51641. Diabetes November 1990 39:1408-1413; doi:10.2337/diabetes.39.11.1408

  4. Frank, B H

    • Effect of bacitracin on retroendocytosis and degradation of insulin in cultured kidney epithelial cell line. Diabetes November 1990 39:1339-1346; doi:10.2337/diabetes.39.11.1339

G

  1. Gerich, J

    • Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes November 1990 39:1381-1390; doi:10.2337/diabetes.39.11.1381

  2. Gibbs, E M

    • Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes. Diabetes November 1990 39:1414-1419; doi:10.2337/diabetes.39.11.1414

  3. Giustina, A

    • Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes November 1990 39:1333-1338; doi:10.2337/diabetes.39.11.1333

  4. Giustina, G

    • Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes November 1990 39:1333-1338; doi:10.2337/diabetes.39.11.1333

H

  1. Haskins, K

    • Anti-islet cell antibodies from NOD mice. Diabetes November 1990 39:1366-1372; doi:10.2337/diabetes.39.11.1366

  2. Henquin, J C

    • Marked improvement of glucose homeostasis in diabetic ob/ob mice given oral vanadate. Diabetes November 1990 39:1326-1332; doi:10.2337/diabetes.39.11.1326
    • Glucose-induced electrical activity in beta-cells. Feedback control of ATP-sensitive K+ channels by Ca2+? [corrected] Diabetes November 1990 39:1457-1460; doi:10.2337/diabetes.39.11.1457

  3. Holloszy, J O

    • Effects of exercise training on insulin-regulatable glucose-transporter protein levels in rat skeletal muscle. Diabetes November 1990 39:1425-1429; doi:10.2337/diabetes.39.11.1425

  4. Ho, R S

    • Inhibition of hepatic glucose production by SDZ 51641. Diabetes November 1990 39:1408-1413; doi:10.2337/diabetes.39.11.1408

  5. Hunt, J V

    • Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes November 1990 39:1420-1424; doi:10.2337/diabetes.39.11.1420

  6. Hutson, N J

    • Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes. Diabetes November 1990 39:1414-1419; doi:10.2337/diabetes.39.11.1414

J

  1. James, D E

    • Effects of exercise training on insulin-regulatable glucose-transporter protein levels in rat skeletal muscle. Diabetes November 1990 39:1425-1429; doi:10.2337/diabetes.39.11.1425

  2. Jean-Didier, N

    • Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes November 1990 39:1361-1365; doi:10.2337/diabetes.39.11.1361

  3. Jenssen, T

    • Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes November 1990 39:1381-1390; doi:10.2337/diabetes.39.11.1381

K

  1. Kawai, K

    • Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Diabetes November 1990 39:1320-1325; doi:10.2337/diabetes.39.11.1320

  2. Kelley, D

    • Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes November 1990 39:1381-1390; doi:10.2337/diabetes.39.11.1381

  3. Klein, B E

    • Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C-peptide and diabetic retinopathy. Diabetes November 1990 39:1445-1450; doi:10.2337/diabetes.39.11.1445

  4. Klein, R

    • Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C-peptide and diabetic retinopathy. Diabetes November 1990 39:1445-1450; doi:10.2337/diabetes.39.11.1445

  5. Knowler, W C

    • Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes November 1990 39:1430-1435; doi:10.2337/diabetes.39.11.1430

  6. Kreutter, D K

    • Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes. Diabetes November 1990 39:1414-1419; doi:10.2337/diabetes.39.11.1414

  7. Kryshak, E J

    • Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes November 1990 39:1373-1380; doi:10.2337/diabetes.39.11.1373

L

  1. Lozano, J

    • Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes November 1990 39:1361-1365; doi:10.2337/diabetes.39.11.1361

M

  1. Marsh, M

    • Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes November 1990 39:1373-1380; doi:10.2337/diabetes.39.11.1373

  2. McIntosh, R H

    • Inhibition of hepatic glucose production by SDZ 51641. Diabetes November 1990 39:1408-1413; doi:10.2337/diabetes.39.11.1408

  3. Mealing, G A

    • Long-term culture of neonatal rat pancreatic endocrine cells as model for insulin-secretion and ion-channel studies. Diabetes November 1990 39:1353-1360; doi:10.2337/diabetes.39.11.1353

  4. Mitrakou, A

    • Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes November 1990 39:1381-1390; doi:10.2337/diabetes.39.11.1381

  5. Mondon, C E

    • Effects of exercise training on insulin-regulatable glucose-transporter protein levels in rat skeletal muscle. Diabetes November 1990 39:1425-1429; doi:10.2337/diabetes.39.11.1425

  6. Monier, L

    • Structural abnormality in LDL from diabetic patients as revealed by resonance Raman spectroscopy. Diabetes November 1990 39:1451-1456; doi:10.2337/diabetes.39.11.1451

  7. Mooradian, A D

    • Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes November 1990 39:1391-1398; doi:10.2337/diabetes.39.11.1391

  8. Morley, J E

    • Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes November 1990 39:1391-1398; doi:10.2337/diabetes.39.11.1391

  9. Moss, S E

    • Wisconsin Epidemiologic Study of Diabetic Retinopathy. XII. Relationship of C-peptide and diabetic retinopathy. Diabetes November 1990 39:1445-1450; doi:10.2337/diabetes.39.11.1445

  10. Mott, D M

    • Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes November 1990 39:1430-1435; doi:10.2337/diabetes.39.11.1430

  11. Mukai, H

    • Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Diabetes November 1990 39:1320-1325; doi:10.2337/diabetes.39.11.1320

  12. Murayama, Y

    • Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Diabetes November 1990 39:1320-1325; doi:10.2337/diabetes.39.11.1320

N

  1. Nadelson, J

    • Inhibition of hepatic glucose production by SDZ 51641. Diabetes November 1990 39:1408-1413; doi:10.2337/diabetes.39.11.1408

  2. Nair, G

    • Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes November 1990 39:1399-1407; doi:10.2337/diabetes.39.11.1399

  3. Nelson, R G

    • Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes November 1990 39:1430-1435; doi:10.2337/diabetes.39.11.1430

O

  1. Ohashi, S

    • Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Diabetes November 1990 39:1320-1325; doi:10.2337/diabetes.39.11.1320

P

  1. Pangburn, T

    • Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes November 1990 39:1381-1390; doi:10.2337/diabetes.39.11.1381

  2. Pettitt, D J

    • Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes November 1990 39:1430-1435; doi:10.2337/diabetes.39.11.1430

  3. Philippot, J R

    • Structural abnormality in LDL from diabetic patients as revealed by resonance Raman spectroscopy. Diabetes November 1990 39:1451-1456; doi:10.2337/diabetes.39.11.1451

  4. Pollet, R J

    • Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes November 1990 39:1399-1407; doi:10.2337/diabetes.39.11.1399

  5. Powell, A M

    • Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes November 1990 39:1436-1444; doi:10.2337/diabetes.39.11.1436

R

  1. Rabkin, R

    • Effect of bacitracin on retroendocytosis and degradation of insulin in cultured kidney epithelial cell line. Diabetes November 1990 39:1339-1346; doi:10.2337/diabetes.39.11.1339

  2. Raccah, D

    • Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes November 1990 39:1361-1365; doi:10.2337/diabetes.39.11.1361

  3. Recant, L

    • Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes November 1990 39:1436-1444; doi:10.2337/diabetes.39.11.1436

  4. Reilly, J

    • Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes November 1990 39:1381-1390; doi:10.2337/diabetes.39.11.1381

  5. Rich, S S

    • Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes November 1990 39:1315-1319; doi:10.2337/diabetes.39.11.1315

  6. Rizza, R A

    • Effect of insulin on oxidation of intracellularly and extracellularly derived glucose in patients with NIDDM. Evidence for primary defect in glucose transport and/or phosphorylation but not oxidation. Diabetes November 1990 39:1373-1380; doi:10.2337/diabetes.39.11.1373

  7. Rodnick, K J

    • Effects of exercise training on insulin-regulatable glucose-transporter protein levels in rat skeletal muscle. Diabetes November 1990 39:1425-1429; doi:10.2337/diabetes.39.11.1425

  8. Romanelli, G

    • Short-term administration of captopril and nifedipine and exercise-induced albuminuria in normotensive diabetic patients with early-stage nephropathy. Diabetes November 1990 39:1333-1338; doi:10.2337/diabetes.39.11.1333

  9. Rostain-Capaillon, O

    • Structural abnormality in LDL from diabetic patients as revealed by resonance Raman spectroscopy. Diabetes November 1990 39:1451-1456; doi:10.2337/diabetes.39.11.1451

S

  1. Saad, M F

    • Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes November 1990 39:1430-1435; doi:10.2337/diabetes.39.11.1430

  2. Sainte-Marie, J

    • Structural abnormality in LDL from diabetic patients as revealed by resonance Raman spectroscopy. Diabetes November 1990 39:1451-1456; doi:10.2337/diabetes.39.11.1451

  3. Schwartz, J L

    • Long-term culture of neonatal rat pancreatic endocrine cells as model for insulin-secretion and ion-channel studies. Diabetes November 1990 39:1353-1360; doi:10.2337/diabetes.39.11.1353

  4. Selam, J L

    • Determination of portal insulin absorption from peritoneum via novel nonisotopic method. Diabetes November 1990 39:1361-1365; doi:10.2337/diabetes.39.11.1361

  5. Smith, C C

    • Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes November 1990 39:1420-1424; doi:10.2337/diabetes.39.11.1420

  6. Solomon, D

    • Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes November 1990 39:1436-1444; doi:10.2337/diabetes.39.11.1436

  7. Standaert, M

    • Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes November 1990 39:1399-1407; doi:10.2337/diabetes.39.11.1399

  8. Stecha, P

    • Anti-islet cell antibodies from NOD mice. Diabetes November 1990 39:1366-1372; doi:10.2337/diabetes.39.11.1366

  9. Stevenson, R W

    • Insulinlike activity of new antidiabetic agent CP 68722 in 3T3-L1 adipocytes. Diabetes November 1990 39:1414-1419; doi:10.2337/diabetes.39.11.1414

  10. Supon, P

    • Anti-islet cell antibodies from NOD mice. Diabetes November 1990 39:1366-1372; doi:10.2337/diabetes.39.11.1366

  11. Suzuki, S

    • Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Diabetes November 1990 39:1320-1325; doi:10.2337/diabetes.39.11.1320

T

  1. Timmers, K I

    • Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes November 1990 39:1436-1444; doi:10.2337/diabetes.39.11.1436

  2. Tsao, T

    • Effect of bacitracin on retroendocytosis and degradation of insulin in cultured kidney epithelial cell line. Diabetes November 1990 39:1339-1346; doi:10.2337/diabetes.39.11.1339

V

  1. Veneman, T

    • Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes November 1990 39:1381-1390; doi:10.2337/diabetes.39.11.1381

  2. Verma, S P

    • Structural abnormality in LDL from diabetic patients as revealed by resonance Raman spectroscopy. Diabetes November 1990 39:1451-1456; doi:10.2337/diabetes.39.11.1451

  3. Vila, M C

    • Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes November 1990 39:1399-1407; doi:10.2337/diabetes.39.11.1399

  4. Voyles, N R

    • Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes November 1990 39:1436-1444; doi:10.2337/diabetes.39.11.1436

W

  1. Watson, J E

    • Sulfonylurea-stimulated glucose transport association with diacylglycerollike activation of protein kinase C in BC3H1 myocytes. Diabetes November 1990 39:1399-1407; doi:10.2337/diabetes.39.11.1399

  2. Whitfield, J F

    • Long-term culture of neonatal rat pancreatic endocrine cells as model for insulin-secretion and ion-channel studies. Diabetes November 1990 39:1353-1360; doi:10.2337/diabetes.39.11.1353

  3. Wilkins, S D

    • Multiple alterations in insulin responses to glucose in islets from 48-h glucose-infused nondiabetic rats. Diabetes November 1990 39:1436-1444; doi:10.2337/diabetes.39.11.1436

  4. Wolff, S P

    • Abnormal redox status without increased lipid peroxidation in sugar cataract. Diabetes November 1990 39:1347-1352; doi:10.2337/diabetes.39.11.1347
    • Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes November 1990 39:1420-1424; doi:10.2337/diabetes.39.11.1420

  5. Woollard, A C

    • Abnormal redox status without increased lipid peroxidation in sugar cataract. Diabetes November 1990 39:1347-1352; doi:10.2337/diabetes.39.11.1347

Y

  1. Yamashita, K

    • Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas. Diabetes November 1990 39:1320-1325; doi:10.2337/diabetes.39.11.1320

  2. Young, D A

    • Inhibition of hepatic glucose production by SDZ 51641. Diabetes November 1990 39:1408-1413; doi:10.2337/diabetes.39.11.1408

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement